|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Research Services, VA medical Center, Minneapolis, Minnesota, United States; Department of Food Science and Nutrition, University of Minnesota, St. Paul, Minnesota, United States
2 Research Services, VA medical Center, Minneapolis, Minnesota, United States
3 Department of Food Science and Nutrition, University of Minnesota, St. Paul, Minnesota, United States; Minnesota Obesity Center, Minneapolis, Minnesota, United States; Research Services, VA medical Center, Minneapolis, Minnesota, United States; Neuroscience, University of Minnesota, Minneapolis, Minnesota, United States
4 Metabolic Section (111G), Minneapolis VA Medical Center, Minneapolis,, Minnesota, United States; Minnesota Obesity Center, Minneapolis, Minnesota, United States
5 Geriatric Research, Education and Clinical Center (11G), Veterans Affairs Medical Center, Minneapolis, Minnesota, United States; Department of Food Science and Nutrition, University of Minnesota, St. Paul, Minnesota, United States; Minnesota Obesity Center, Minneapolis, Minnesota, United States; Graduate Program in Neuroscience, University of Minnesota, Minneapolis, Minnesota, United States
* To whom correspondence should be addressed. E-mail: cwang{at}umn.edu.
Recent studies show that brain-derived neurotrophic factor (BDNF) decreases feeding and body weight after peripheral and ventricular administration. BDNF mRNA and protein, and its receptor, TrkB, are widely distributed in the hypothalamus and other brain regions. However, there are few reports on specific brain sites of actions for BDNF. We evaluated the effect of BDNF, given into the ventromedial nucleus of the hypothalamus (VMH), on normal, deprivation- and NPY- induced feeding behavior and body weight. BDNF injected unilaterally or bilaterally into the VMH of food-deprived and non-deprived rats significantly decreased feeding and body weight gain within the 0-24 h and 24-48 h post-injection intervals. Doses effectively producing inhibition of feeding behavior did not establish a conditioned taste aversion. BDNF-induced feeding inhibition was attenuated by pretreatment of the TrkB-Fc fusion protein that blocks binding between BDNF and its receptor TrkB. VMH-injected BDNF significantly decreased VMH neuropeptide Y (NPY)-induced feeding at 1, 2 and 4 h following injection. In summary, BDNF in the VMH significantly decreases food intake and body weight gain, by TrkB receptor mediated actions. Furthermore, the anorectic effects of BDNF in this site appear to be mediated by NPY. These data suggest that the VMH is an important site of action for BDNF in its effects on energy metabolism.
This article has been cited by other articles:
![]() |
B. Bariohay, C. Tardivel, J. Pio, A. Jean, and B. Felix BDNF-TrkB signaling interacts with the GABAergic system to inhibit rhythmic swallowing in the rat Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1050 - R1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Han, Q.-R. Liu, M. Jones, R. L. Levinn, C. M. Menzie, K. S. Jefferson-George, D. C. Adler-Wailes, E. L. Sanford, F. L. Lacbawan, G. R. Uhl, et al. Brain-Derived Neurotrophic Factor and Obesity in the WAGR Syndrome N. Engl. J. Med., August 28, 2008; 359(9): 918 - 927. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Patterson, A. A. Dunn-Meynell, and B. E. Levin Three weeks of early-onset exercise prolongs obesity resistance in DIO rats after exercise cessation Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R290 - R301. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Unger, G. A. Calderon, L. C. Bradley, M. Sena-Esteves, and M. Rios Selective Deletion of Bdnf in the Ventromedial and Dorsomedial Hypothalamus of Adult Mice Results in Hyperphagic Behavior and Obesity J. Neurosci., December 26, 2007; 27(52): 14265 - 14274. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |